Business Wire

• CT-P47 was highly similar in terms of efficacy and safety to the reference product RoActemra® (tocilizumab) for the treatment of rheumatoid arthritis (RA) up to week 321
• High usability of the CT-P47 autoinjector (AI) was observed in RA patients, offering greater flexibility and an alternative treatment option

INCHEON, South Korea--(BUSINESS WIRE)-- Celltrion today presented positive Phase III data for CT-P47, a biosimilar candidate referencing RoActemra® in... (continue reading...)

Emerges from Chapter 11 with robust liquidity position after eliminating all prepetition debt

New shareholder group, led by Nexus Capital Management, to support Company’s continued strategic transformation to best serve the healthcare community

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Careismatic Brands, LLC (“CBI” or “the Company”), the world’s largest medical apparel provider, today announced that it has emerged from Chapter 11 following confirmation of the... (continue reading...)

NEW YORK--(BUSINESS WIRE)-- Sound Point Meridian Capital, Inc. (NYSE: SPMC) (the “Company”) today announced the pricing of its initial public offering of 4,000,000 shares of common stock at a public offering price of $20.00 per share, which will result in net proceeds to the Company of approximately $79.7 million after payment of certain offering expenses. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 600,000... (continue reading...)

SAN FRANCISCO & LOS ANGELES--(BUSINESS WIRE)-- GroundForce Capital, an investment management firm that backs high-potential B2B and B2C companies seeking to improve the health and longevity of people and the planet, is pleased to announce the sale of Only What You Need (OWYN) to The Simply Good Foods Company (Nasdaq: SMPL) for $280 million. OWYN is the fastest-growing ready-to-drink (RTD)(1) protein shake brand in the market that unites great taste and ingredient... (continue reading...)

EXTON, Pa.--(BUSINESS WIRE)-- Innovative Solutions & Support, Inc. (“IS&S” or the “Company”) (NASDAQ: ISSC) announced its response to the unsolicited, non-binding indication of interest to make a proposal from Christopher Harborne (the “Non-Binding Indication of Interest”). The Non-Binding Indication of Interest contemplates a transaction in which Mr. Harborne would acquire all of the shares of the Company’s common stock not already owned by Mr. Harborne at a price... (continue reading...)